Our approach to bioresilience

The global biosecurity landscape is rapidly evolving. Shifting natural ecosystems, global travel and the potential misuse of AI require greater vigilance — yet AI is also a critical tool for our response. We need frontier AI models, and the scientific advances they will enable , to respond to these challenges and help make society more resilient to events like future outbreaks.

Today, Google DeepMind and Isomorphic Labs are sharing our joint approach to bioresilience .

Our work is twofold - to prevent threat actors from misusing our models, and to ensure that governments, scientists, biosecurity experts and our teams can harness these technologies to build a more resilient world.

Breakthroughs like Google DeepMind’s AlphaFold , which mapped the 3D structures of nearly all known proteins; Isomorphic Labs’ AI-powered Drug Design Engine (IsoDDE), which provides the real-world accuracy required to navigate novel biological systems with unprecedented precision; and AlphaGenome, which sheds light on genome function, are radically shifting the balance. Instead of just reacting to natural outbreaks or safety risks, we can now use these intelligent systems to help researchers design proactive defenses, accelerate the discovery of therapeutics, and safeguard the global health ecosystem with greater speed and precision.

We are helping make pathogen surveillance more cost-effective. For example, our agent AlphaEvolve can optimize algorithms used for producing and analyzing metagenomic sequencing data, helping detect new outbreaks faster. This optimization allows for quicker and more accurate DNA analysis, making it cheaper to track diseases worldwide on a large scale.

To support government bodies and non-profit organizations during novel outbreaks, Isomorphic Labs has established a focused unit to rapidly deploy its drug design engine to design medical countermeasures that could address both naturally occurring pandemics and potential risks arising from the misuse of advanced AI. Working in collaboration with governments and global health authorities to advance a diverse range of diagnostic and therapeutic strategies enables the Isomorphic Labs Drug Design Engine’s real-world impact for bioresilience.

With this in mind, we are making our AI models and agents available to trusted partners to support progress across three key areas: prevention, detection and response. Here are some examples:

Over the past 12 months, we have advanced more than 15 partnerships with government bodies, biosecurity organizations, and research groups to prevent threat actors from misusing our models, detect new outbreaks quickly and respond quickly and effectively.

We believe society must harness AI’s advancing capabilities to address infectious diseases and prepare for future outbreaks.

To ensure our models, like Gemini, are safe and useful to experts, we follow a four-step safety process: threat modeling, evaluations, mitigations and monitoring.